Pediatric obstructive sleep apnea hypopnea diagnosis using a video recording score: A pilot study - 02/06/26
, J.-E. Petersen a, C. Lambert b, M. Puechmaille a, L. Gilain a, T. Mom a, Y. Dauvilliers c, M.-L. Fantini d, P. Beudin d, M. Akkari eAbstract |
Objectives |
Because access to sleep recordings is limited, there is a need for new reliable tools for pediatric obstructive sleep apnea-hypopnea syndrome (OSAHS) diagnosis. A score calculated from a 30 minutes-home sleep video recording (VR) has already been proposed in 1996 with interesting results. The main objective of this pilot study was to assess the reliability of a similar score applied to reference PSG VR and calculated on two different time windows (30 and 10 minutes).
Methods |
A retrospective monocenter study was made on 16 children suspected of OSAHS, that underwent VR during overnight PSG. Video analysis was made during the second complete sleep cycle. A 30-minute risk score (RS30) and a 10-minute risk score (RS10) were established by analyzing seven parameters. The RS30 and RS10 were correlated with clinical examination data, a sleep questionnaire, the obstructive-apnea-hypopnea index (OAHI) and the oxygen desaturation index (ODI) from synchronized PSG results.
Results |
There was a significant correlation between both the RS30 and RS10, the OAHI and ODI. A RS30 ≥6.09 was predictive of an OAHI ≥5 per hour with a sensitivity of 83% and a specificity of 90%. A RS10 ≥6.50 was predictive of an OAHI ≥5 per hour with a sensitivity of 67% and a specificity of 100%.
Conclusion |
A risk score based on PSG VR shows a good correlation with PSG results, confirming previous reports. Further work should focus on applying this risk score to home sleep VR for the diagnosis of pediatric OSAHS.
Le texte complet de cet article est disponible en PDF.Keywords : Pediatric obstructive sleep apnea hypopnea syndrome, Pediatric sleep disordered breathing, Sleep video recording, Polysomnography
Plan
| ☆ | This article was presented as an oral communication at the SFORL 2021 (Paris, France) and CEORL-HNS 2024 (Dublin Ireland) conference meetings, and as a poster at the SFRMS 2022 (Lille France) and IPSA 2024 (Glasgow 2024) conference meetings. |
Vol 143 - N° 3
P. 181-186 - mai 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
